Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangement of Certain Officers.
On January 25, 2021, Aravive, Inc. (the "Company") entered into an amendment
(the "McIntyre Amendment"), to the Offer Letter (the "McIntyre Offer Letter")
that it had entered into with Gail McIntyre, Ph.D., the Company's Chief
Executive Officer, on March 26, 2020, as amended on April 8, 2020. The McIntyre
Amendment provides that Dr. McIntyre will receive: (i) effective as of January
1, 2021, an annual base salary of $500,000, less required deductions and
withholdings, payable in accordance with the Company's standard payroll
schedule, for service as the Company's Chief Executive Officer; and (ii) a
target bonus equal to 50% of Dr. McIntyre's annual base salary. All other terms
of the McIntyre Offer Letter shall remain in full force and effect. On January
25, 2021, Dr. McIntyre was also granted a cash bonus of $149,400 for the
Company's 2020 fiscal year and an option to purchase 165,000 shares of the
Company's common stock with an exercise price of $5.95 per share and vesting pro
rata on a monthly basis over a four- year period.
The foregoing description of the McIntyre Amendment do not purport to be
complete and are qualified in their entirety by reference to copy of the
McIntyre Amendment, which are filed as Exhibit 10.1, to this Current Report on
Form 8-K and are incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit Description
10.1 Amendment to Offer Letter dated as of January 25, 2021 by and between
Aravive, Inc. and Gail McIntyre, Ph.D.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses
ARAVIVE, INC. 
